Hillhurst Biopharmaceuticals, Inc.   Report issue

For profit Phase 1
Founded: Montrose CA United States (2012)

Organization Overview

First Clinical Trial
2019
NCT03926819
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Hillhurst Biopharmaceuticals, Inc.